Jeffrey R Infante

Jeffrey R Infante

Johnson & Johnson Co. - New Jersey / United States
Others
AD Scientific Index ID: 4375550
-
person_outline Jeffrey R Infante's MOST POPULAR ARTICLES
1-) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabineDD Von Hoff, T Ervin, FP Arena, EG Chiorean, J Infante, M Moore, T Seay, ...New England Journal of Medicine 369 (18), 1691-1703, 201355332013
2-) Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutationsKT Flaherty, JR Infante, A Daud, R Gonzalez, RF Kefford, J Sosman, ...New England Journal of Medicine 367 (18), 1694-1703, 201228732012
3-) Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1 …JG Berdeja, D Madduri, SZ Usmani, A Jakubowiak, M Agha, AD Cohen, ...The Lancet 398 (10297), 314-324, 202110432021
4-) Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialGS Falchook, GV Long, R Kurzrock, KB Kim, TH Arkenau, MP Brown, ...The Lancet 379 (9829), 1893-1901, 201210372012
5-) First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvementJ Tabernero, GI Shapiro, PM LoRusso, A Cervantes, GK Schwartz, ...Cancer discovery 3 (4), 406-417, 20137972013